3,4-Ethylenedioxyamphetamine

Not to be confused with 3,4-Ethylidenedioxyamphetamine.

3,4-Ethylenedioxyamphetamine (EDA), also known as EDA-6, is a drug of the amphetamine family related to 3,4-methylenedioxyamphetamine (MDA).^[1] It is closely related to analogues including 3,4-ethylenedioxymethamphetamine (EDMA), 3,4-ethylidenedioxyamphetamine (EIDA), and 3,4-isopropylidenedioxyamphetamine (IDA).^[1][2] EDMA, the N-methylated analogue of EDA, is known to be a serotonin–norepinephrine–dopamine releasing agent (SNDRA).^[3] According to Alexander Shulgin however, the drug only produced limited psychoactive effects in humans at doses in the range of 150 to 250 mg.^[4][1]

EDA

Clinical data
Other names	3,4-Ethylenedioxyamphetamine; EDA; EDA-6; α-Methyl-1,4-benzodioxan-6-ethylamine
Identifiers
IUPAC name 1-(2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
CAS Number	15033-67-7
PubChem CID	5017291
ChemSpider	4196440
Chemical and physical data
Formula	C11H15NO2
Molar mass	193.246 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(CC1=CC2=C(C=C1)OCCO2)N
InChI InChI=1S/C11H15NO2/c1-8(12)6-9-2-3-10-11(7-9)14-5-4-13-10/h2-3,7-8H,4-6,12H2,1H3 Key:HDECLNXLHDXDKE-UHFFFAOYSA-N

See also

• 3,4-Ethylenedioxymethamphetamine (EDMA)
• 3,4-Ethylenedioxymethcathinone (EDMC)
• 3,4-Ethylidenedioxyamphetamine (EIDA)
• 3,4-Isopropylidenedioxyamphetamine (IDA)
• 3,4-Dimethoxyamphetamine (DMA)